Mediwhale is the AI-empowered health diagnostics company that uses non-invasive retina scans to help prevent heart and kidney diseases. Mediwhale’s Reti-Intelligence suite of services uses deep learning algorithms to detect disease risks even before symptoms appear. Mediwhale has been dedicated to making preventative care more affordable, accessible, safe, and convenient since being founded in 2016 in South Korea. Mediwhale has product approvals in 8 territories in Europe and Asia (including EU, UK, Australia, Korea), and is under FDA approval.
Company Details
- Employees
- 40
- Founded
- -
- Address
- 4f, 746 Nonhyeon-Ro, Gangnam-Gu, Seoul,06049,korea, Republic Of
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- medi-whale.com
- HQ
- Seoul
Mediwhale Questions
Mediwhale's website is medi-whale.com
Mediwhale's LinkedIn profile is https://kr.linkedin.com/company/mediwhale
Mediwhale has
40 employees.
View email and phone details for 40
employees at Mediwhale.
Mediwhale's industry is
Software Development
Mediwhale's top competitors are
Airs Medical,
Icardio.ai,
Alimetry,
Lunit Cancer Screening,
Promedius,
Heart Eye,
Vuno Inc.,
Qure.ai,
Aitrics,
Retispec.
Mediwhale's categories are Software Development
Mediwhale's founding year is 2016
